Personalized Medicine

The old paradigm of one blockbuster drug that works for everyone has already become ancient history. As pharma evolves and recognizes the uniqueness of each individual disease, there is a growing certainty based on new methods of molecular analysis that particular drugs work better in subsets of patients who could not be previously identified or segregated. In previous clinical trials, there have been subsets of patients that either thrived on the drug and others who reaped nothing but side effects from the drug being studied.

By personalizing medicine, however, and making use of information about a person’s genes, proteins, and environment, we are now better able to prevent, diagnose, and treat disease.

It’s now estimated that to bring a drug to market in the United States costs more than $1.2 billion. While novel therapies may be effective in clinical trials with a select group of patients, patients often respond differently to new drugs and the drugs don’t always work outside of the limited clinical testing sphere. The costs and consequences of treatment failure are significant. Drug ineffectiveness can range from an average of 75% for cancer drugs, to over 40 and 50% for new diabetes and arthritis medications, respectively. 

However, by using new companion diagnostics such as EndoPAT with the new generation of agents currently in development, Pharma can preselect those patients most likely to benefit from and exclude those likely to be harmed by a new drug. Companion diagnostics can reduce the cost of drug development by facilitating clinical testing, and allow health insurance companies to offer safer and better drugs with predictable outcomes, ultimately helping lower the cost of patient care. 

Contact Us

For More Information

Itamar Understands:

That Pharma Wants To Develop And Sell Drugs

• Itamar focuses on meeting Pharma needs
• Developing companion diagnostic tests
• Winning regulatory approval

That Providers Want To Save Money

• We focus our efforts on meeting the needs of national pharmacy benefits managers

That Patients Want The Best Results

• We focus on selecting the best treatment and reducing unnecessary drug usage

Back To Top | Contact Us | Companion Diagnostic Program | Itamar Pharma Team